Discover cutting-edge studies on carcinogenesis, biomarkers, and targeted therapeutic approaches
Explore how peptide-based inhibitors are targeting ADAM and ADAMTS metalloproteinases to treat diseases like cancer, arthritis, and Alzheimer's with unprecedented precision.